Successful Treatment of Spondylodiscitis and Infectious Sacroiliitis due to Listeria monocytogenes using Meropenem as Salvage Therapy
Abeline Kapuczinski1,2, Sammy Place1, Olivier Filleul1, Christine Villers2
1 Department of Internal Medicine, Centre Hospitalier EpiCURA, Hornu, Belgium
2 Department of Rheumatology, Centre Hospitalier EpiCURA, Hornu, Belgium
Doi: 10.12890/2022_003177 - European Journal of Case Reports in Internal Medicine - © EFIM 2021
Received: 09/01/2022
Accepted: 12/01/2022
Published: 11/03/2022

How to cite this article:Kapuczinski A, Place S, Filleul O, Villers C. Successful treatment of spondylodiscitis and infectious sacroilitis due to Listeria mono cytogenes using meropenem as salvage therapy EJCRIM 2022;9 doi:10.12890/2022_003177.

Conflicts of Interests: The authors declare there are no competing interests.
This article is licensed under a Commons Attribution Non-Commercial 4.0 License

ABSTRACT

Infectious sacroiliitis is a rare disease that can occur in conjunction with other osteoarticular infections. Furthermore, it is very unusual for Listeria monocytogenes to be identified in an osteoarticular infection, with spondylodiscitis being the most frequent such infection. We report a case of spondylodiscitis with infectious sacroiliitis due to infection with L. monocytogenes treated successfully with meropenem as salvage therapy.

LEARNING POINTS

KEYWORDS

Spondylodiscitis, sacroiliitis, osteoarticular infection, Listeria monocytogenes

INTRODUCTION

AInfectious spondylodiscitis is defined as infection of the intervertebral disc and adjacent vertebral bodies, and has a prevalence of 3-5 cases per 100 000 population[1, 2]. Infectious sacroiliitis is an inflammation of the sacroiliac joint [3] and is rare, affecting 1–2% of septic arthritis cases. Usually unilateral, it can be accompanied by other osteoarticular infections including spondylodiscitis [4]. Both often occur as a result of haematogenous spread from a distant origin. Medical imaging plays a major role in diagnosis, especially magnetic resonance imaging (MRI[2].
Listeria monocytogenes is a Gram-positive bacillus which causes gastro-intestinal infection and occasionally meningitis and meningoencephalitis, which mostly affect the elderly. It is more common in immunocompromised patients, pregnant women and very old individuals. Contamination usually occurs following consumption of raw dairy products, eggs and meat [5, 6]. It is highly unusual for it to be identified in an osteoarticular infection [7].
We report a case of spondylodiscitis with concomitant infectious sacroiliitis caused by L. monocytogenes.

CASE DESCRIPTION

An 80-year-old woman was admitted to the rehabilitation unit after she fell while on holiday in Algeria. She had vertebral collapse of T12 and L5 and multiple rib fractures. Her medical history included atrial fibrillation, hypertension, diabetes, KDIGO stage IIIa chronic kidney disease and osteopenia. Soon after admission, she developed rigors and fever. The general examination was normal, except for chronic back pain. Blood tests showed an elevated C-reactive protein level of 141 mg/l and blood cultures grew L. monocytogenes after 25 hours of incubation. No gastroenteritis was mentioned by the patient in her medical history, but she confessed to having consumed unpasteurized milk and cheese during her visit to Algeria.
Computed tomography of the abdomen showed L4–L5 spondylodiscitis combined with right sacroiliitis (Figs. 1 and 2). The diagnosis was confirmed with MRI (Fig. 3) and infectious endocarditis was ruled out with transoesophageal echocardiography. Antibiotic therapy with continuous intravenous penicillin and rifampin was first started as bitherapy. Gentamicin was avoided because of the patient’s age and the grade III chronic kidney disease. Rifampin was rapidly switched to cotrimoxazole because of oral intolerance, and treatment was then switched to meropenem on the seventh day, as the patient developed acute kidney injury, leukocytopenia, and recurrent CRP elevation. Meropenem was well tolerated, and the patient’s clinical and biological condition improved. Treatment was prolonged for a further 42 days, MRI at 3-month follow-up showed regression of the lesions (Fig. 4), and no relapse was observed at 1-year follow-up.

Figure 1 (click to enlarge)

Figure 2 (click to enlarge)

Figure 1. CT of the abdomen at the onset of disease showing L4–L5 spondylodiscitis
Figure 2. CT of the abdomen at the onset of disease showing right sacroiliitis

Figure 3 (click to enlarge)

Figure 4 (click to enlarge)

Figure 3. MRI confirming L4–L5 spondylodiscitis at the onset of disease
Figure 4. MRI at 3-month follow-up showing regression of the lesions

DISCUSSION

Listeriosis is a foodborne illness brought about by the consumption of contaminated foods, particularly unpasteurized milk, soft cheeses, vegetables and undercooked meat products. L. monocytogenes mostly causes enteritis with a mild acute fever syndrome, that can sometimes become more severe, mostly in immunocompromised patients. The key risk factors are extreme age, pregnancy, diabetes, cancer, immunosuppressive drugs, autoimmune diseases, HIV, alcoholism and liver cirrhosis [8, 9]. In this case, L. monocytogenes infection was presumably caused by the ingestion of raw dairy products in Algeria.
Pyogenic sacroiliitis is very rare, accounting for less than 2% of infectious arthritis cases. Osteoarticular infection due to L. monocytogenes is unusual with very few cases reported [7, 10–12]. According to Schett et al.[11], joint involvement often occurs in middle-aged patients and usually affects the large joints such as the hip or knee due to haematogenous spread. Spondylodiscitis due to L. monocytogenes has recently been reported [7, 12] but seems to be rare, and to our knowledge, this is the first description of septic sacroiliitis due to listeria. Regarding medical imaging, MRI is the gold standard to diagnose spondylodiscitis or sacroiliitis, owing to its good sensitivity and specificity[3]. Involvement of soft tissues and the epidural space are best evaluated after contrast injection [12]. In our case, concomitant bacteraemia allowed identification of the causal agent without invasive sampling.
The treatment recommended by guidelines includes amoxicillin or penicillin and gentamicin for at least 6 weeks [2, 7, 13]. Gentamicin should be avoided in case of renal failure or if the patient takes other nephrotoxic drugs [14]. If gentamicin cannot be used, the recommended treatment is a combination of ampicillin plus trimethoprim-sulfamethoxazole (TMP-SMX) [15]. Alternative bitherapy with TMP-SMX and gentamicin is considered in case of suspected immunoglobulin E-mediated penicillin allergy [13]. If neither penicillin nor TMP-SMX can be used, meropenem is an alternative treatment [16]. Meropenem has been proposed as salvage therapy or in intolerance to classic treatment, and was successful in our case.

CONCLUSION

To our knowledge, this is the first published case of spondylodiscitis associated with sacroiliitis due to L. monocytogenes. Listeriosis usually affects pregnant women, and extremely old or immunocompromised patients, and is a rare cause of septic arthritis. The guidelines recommend antibiotic treatment with amoxicillin or penicillin and gentamicin for at least 6 weeks. Meropenem was successful in our case. Medical imaging, especially MRI, and blood cultures played a major role in the diagnosis.

References
  1. Amini MH, Salzman GA. Infectious spondylodiscitis: diagnosis and treatment. Mo Med 2013;110(1):80–84.
  2. Herren C, Jung N, Pishnamaz M, Breuninger M, Siewe J, Sobottke R. Spondylodiscitis: diagnosis and treatment options. Dtsch Arztebl Int 2017 Dec;114(51–52):875–882.
  3. Woytala PJ, Sebastian A, Błach K, Silicki J, Wiland P. Septic arthritis of the sacroiliac joint. Reumatologia 2018;56(1):55–58.
  4. Hermet M, Minichiello E, Flipo RM, Dubost JJ, Allanore Y, Ziza JM, et al. Infectious sacroiliitis: a retrospective, multicentre study of 39 adults. BMC Infect Dis 2012 Nov 15;12:305.
  5. Farber JM, Peterkin PI. Listeria monocytogenes, a food-borne pathogen. Microbiol Rev 1991 Sep;55(3):476–511.
  6. Jemmi T, Stephan R. Listeria monocytogenes: food-borne pathogen and hygiene indicator. Rev Sci Tech 2006 Aug;25(2):571–580.
  7. Aubin GG, Boutoille D, Bourcier R, Caillon J, Lepelletier D, Bémer P, et al. Unusual case of spondylodiscitis due to Listeria monocytogenes. J Bone Jt Infect 2016 Feb 29;1:7–9.
  8. Barbuddhe SB, Chakraborty T. Listeria as an enteroinvasive gastrointestinal pathogen. Curr Top Microbiol Immunol 2009;337:173–195.
  9. Allerberger F, Huhulescu S. Pregnancy related listeriosis: treatment and control. Expert Rev Anti Infect Ther 2015 Mar;13(3):395–403.
  10. Khan KM, Pao W, Kendler J. Epidural abscess and vertebral osteomyelitis caused by Listeria monocytogenes: case report and literature review. Scand J Infect Dis 2001;33(9):714–716.
  11. Schett G, Herak P, Graninger W, Smolen JS, Aringer M. Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature. J Clin Microbiol 2005 May;43(5):2537–2541.
  12. Al Ohaly R, Ranganath N, Saffie MG, Shroff A. Listeria spondylodiscitis: an uncommon etiology of a common condition; a case report. BMC Infect Dis 2020 July 31;20(1):559.
  13. Pagliano P, Arslan F, Ascione T. Epidemiology and treatment of the commonest form of listeriosis: meningitis and bacteraemia. Infez Med 2017 Sep 1;25(3):210–216.
  14. Bertino JS, Booker LA, Franck PA, Jenkins PL, Franck KR, Nafziger AN. Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring. J Infect Dis 1993 Jan;167(1):173–179.
  15. Spitzer PG, Hammer SM, Karchmer AW. Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature. Rev Infect Dis 1986 Jun;8(3):427–430.
  16. Manfredi R, Sabbatani S, Marinacci G, Salizzoni E, Chiodo F. Listeria monocytogenes meningitis and multiple brain abscesses in an immunocompetent host. Favorable response to combination linezolid-meropenem treatment. J Chemother 2006 Jun;18(3):331–333.